19-51225517-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_001772.4(CD33):āc.337A>Gā(p.Asn113Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000404 in 1,610,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001772.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD33 | NM_001772.4 | c.337A>G | p.Asn113Asp | missense_variant | 2/7 | ENST00000262262.5 | NP_001763.3 | |
LOC107985327 | XR_007067309.1 | n.232-30857T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD33 | ENST00000262262.5 | c.337A>G | p.Asn113Asp | missense_variant | 2/7 | 1 | NM_001772.4 | ENSP00000262262 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152172Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000113 AC: 28AN: 246938Hom.: 0 AF XY: 0.000142 AC XY: 19AN XY: 133588
GnomAD4 exome AF: 0.0000432 AC: 63AN: 1458104Hom.: 0 Cov.: 33 AF XY: 0.0000634 AC XY: 46AN XY: 725266
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152172Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2024 | The c.337A>G (p.N113D) alteration is located in exon 2 (coding exon 2) of the CD33 gene. This alteration results from a A to G substitution at nucleotide position 337, causing the asparagine (N) at amino acid position 113 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at